The mission of the Mass Spectrometry Shared Resource (MSSR) is to provide Cancer Therapy &Research Center (CTRC) members and University of Texas Health Science Center (UTHSCSA) investigators with comprehensive, state-of-the-art support for characterization and quantification of proteins, metabolites and other biomedically important molecules using mass spectrometry. The MSSR has been in operation since 1979 and became a Cancer Center Shared Resource in 1998. There are two components of the MSSR, proteomics and metabolomics, which operate at two locations, a 713 sq. ft. space (Proteomics) on the Long (main) campus of the UTHSCSA and a 782 sq. ft. space (Metabolomics) on the Greehey (north) campus of the UTHSCSA in the South Texas Research Facility (STRF). The MSSR is jointly managed by the University and the CTRC. The MSSR services include molecular mass determination, protein identification, protein quantification, sequence characterization of peptides, localization covalent modification, and metabolomics (discovery experiments, targeted quantitative analysis, and small molecule analysis by GC-MS). The shared resource also offers consultations and training to CTRC investigators. The MSSR is directed by Susan Weintraub, Ph.D. The staff of the MSSR includes two-technical Directors, Kevin W. Hakala, M.S, (Proteomics) and Xiaoli Gao, Ph.D., (Metabolomics) with Sam Pardo as the Core Facilities Technologist. The MSSR team has expertise in the use of mass spectrometry to solve important cancer-related questions. During the last award year, the MSSR serviced 14 peer-review funded cancer center members, which comprised 19% of the total core users and contributed to 29 cancer-related peer-reviewed publications during the last funding period. Usage for the first half of 2013 increased two-fold, likely due to the addition of Metabolomics as a service.
The MSSR supports CTRC investigators who are studying many different aspects of cancer related to fundamental processes, cancer metastasis, and cancer treatment. Analyses of proteins, peptides, small molecule metabolites, and candidate therapeutic agents are conducted by expert technical staff. These efforts provide essential information to elucidate mechanisms of cancer development and assess better ways to treat this deadly disease.
|Du, Liqin; Zhao, Zhenze; Suraokar, Milind et al. (2018) LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget 9:29601-29618|
|Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203|
|Sun, Xiujie; Gupta, Kshama; Wu, Bogang et al. (2018) Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. J Biol Chem 293:2841-2849|
|Horning, Aaron M; Wang, Yao; Lin, Che-Kuang et al. (2018) Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. Cancer Res 78:853-864|
|Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj et al. (2018) Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32:F5-F13|
|Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21|
|Soteros, Breeanne M; Cong, Qifei; Palmer, Christian R et al. (2018) Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene. PLoS One 13:e0199399|
|Katti, Sachin; Her, Bin; Srivastava, Atul K et al. (2018) High affinity interactions of Pb2+ with synaptotagmin I. Metallomics 10:1211-1222|
|De La Chapa, Jorge J; Singha, Prajjal Kanti; Lee, Debbie R et al. (2018) Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis. J Oral Pathol Med 47:674-682|
|Wang, Zhonghua; Bhattacharya, Akash; White, Tommy et al. (2018) Functionality of Redox-Active Cysteines Is Required for Restriction of Retroviral Replication by SAMHD1. Cell Rep 24:815-823|
Showing the most recent 10 out of 989 publications